E

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Financial Analyst - Corporate Finance, BD and M&A

Corporate Finance & FP&AUpdated on Nov 10
Full-timeAlameda, CA, USA

About the Job

Requirements

  • A BS/BA degree in a related discipline and 3 years of related experience, or an MBA degree in a related discipline and 1 year of related experience, or an equivalent combination of education and experience.
  • Strong expertise in financial modeling and financial statement analysis using generally accepted accounting principles and non-GAAP measures.
  • Advanced knowledge of Excel, PowerPoint, and FactSet or comparable financial analytics tools such as Bloomberg or Capital IQ.
  • Advanced Excel modeling skills.
  • Ability to understand operational drivers of financial analyses.
  • Ability to translate financial analyses into clear business implications and communicate them to cross-functional teams and leadership.

Responsibilities

  • Prepare company and asset valuation analyses for potential licensing and mergers and acquisitions transactions.
  • Build merger consequence models to evaluate potential acquisitions.
  • Evaluate in-licensing opportunities from a financial and business perspective.
  • Test deal economics sensitivity to variances in key assumptions, including synergies.
  • Contribute to preparing and presenting deal summaries and recommendations to senior management.
  • Build and update long-range planning models and assist in preparing Board of Directors presentations.
  • Perform discounted cash flow analyses to support lifecycle management of pipeline assets.
  • Perform company-level and project-level valuation analyses.
  • Perform value-added analyses, including resource allocation, profitability analysis, sensitivity and scenario analyses, and benchmarking.
  • Evaluate and compare financial benefits of lifecycle management initiatives and alternatives.
  • Build analyses supporting business partner recommendations on investment and divestment decisions to executive management and the Board of Directors.
  • Build and maintain effective relationships with cross-functional stakeholders to support collaboration, alignment, and execution of business priorities.
  • Develop and standardize financial analysis models using financial analysis techniques, including scenario modeling.
  • Assist in developing cost-effective strategies to finance business initiatives and optimize the company's capital structure.
  • Perform comparable company analyses of biotechnology peers across financings, capital structure, deal-making, share performance, and other areas.
  • Create company profiles on biotechnology and pharmaceutical peers.
  • Maintain the corporate weighted average cost of capital calculation.
  • Monitor industry news, trends, and market dynamics.
  • Perform other duties as assigned and comply with company policies and standards.

Desired Qualifications

  • Experience in investment banking or management consulting.
  • Experience in the biotechnology or pharmaceutical industry.
  • Experience working with cross-functional teams.
  • Expertise evaluating and modeling funding arrangements such as revolving credit facilities, term loans, and equity issuances.
  • Knowledge of the biotechnology and pharmaceutical industry.

About the Company

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Exelixis develops and commercializes medicines for cancer. Its products aim to treat advanced cancers, including renal cell carcinoma, by targeting multiple biological pathways and supporting combination regimens to achieve effective, tolerable, and durable responses. The company generates revenue from sales of approved therapies and strategic partnerships, backed by extensive research, clinical trials, and regulatory approvals to bring new drugs to market. Compared with peers, Exelixis focuses on a pipeline that combines multi-pathway targeting with combination therapies to improve patient outcomes. Its overall goal is to advance cancer treatment and offer patients better chances of remission through its ongoing drug development programs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Francisco, CA
Founded
1994

Recently Posted Jobs

Explore more opportunities at Exelixis

See more jobs